Vantage Data Centers to Continue Deploying Renewable Generator Fuel, Plans Rollout in Additional Markets in 2023
13.9.2023 15:02:00 EEST | Business Wire | Press release
Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the continued deployment of hydrotreated vegetable oil (HVO), a renewable fuel to replace conventional diesel fuel in generators. The company will roll out HVO in several of its largest markets in North America and EMEA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230913529341/en/
Vantage Data Centers continues rollout of HVO in several of its largest markets, including its Cardiff campus pictured here. (Photo: Business Wire)
HVO is 100% biodegradable and non-toxic, offering a more sustainable fuel option while delivering the same level of functionality as traditional diesel. Repurposing waste oils like vegetable oil to create sustainable fuels significantly reduces the embodied carbon due to the cleaner sourcing and creation process. Leveraging HVO offers an actionable opportunity for Vantage and other data center operators to take a positive step toward reducing carbon emissions.
Initially deployed as a pilot at Vantage’s Cardiff, Wales campus in 2022, the company’s deployment of HVO as an alternative to diesel fuel yielded progress toward its carbon goals without the need for new or updated infrastructure. Given the success of the pilot, Vantage officially implemented HVO at its newest facility, CWL13, on the Cardiff campus and is currently working to deploy the renewable fuel throughout the rest of the campus. In addition, Vantage will deploy HVO in one of its North American flagship markets, Santa Clara, California, by the end of the year. Vantage is planning deployments in additional markets subject to fuel availability.
“Making the switch to renewable diesel is one of the many ways we are reducing the carbon emissions of our operations. Reaching net zero by 2030 is an incredibly ambitious goal that will require us to implement a wide variety of solutions. Our focus is on maintaining reliability and affordability while achieving emissions reductions,” said Amanda Abell, senior director of sustainability at Vantage. “We look forward to continuing the rollout of HVO at our campuses across North America and EMEA, where available, in addition to the other programs we have in place to reach our sustainability targets.”
The broad launch of hydrotreated vegetable oil comes as the company progresses toward its sustainability goals. The use of renewable diesel fuels significantly reduces the embodied carbon of the fuel consumed in diesel generators, which helps to reduce Scope 3 emissions associated with the company’s supply chain. According to fuel suppliers, the use of HVO reduces the lifecycle carbon emissions by 65-90% compared to conventional diesel.
In 2022, Vantage partnered with the Data Center Coalition (DCC) and its members to lead a technical working group focused on driving market support for HVO as availability and costs vary by geography. Based in the Northern Virginia area, where HVO prices are approximately 95 percent higher than diesel fuel, DCC seeks to influence the supply chain and stakeholders to unlock increased availability.
“Vantage is working with industry through the Data Center Coalition to accelerate the viability and use of renewable diesel fuels,” said Mark Freeman, vice president, global marketing and public policy at Vantage and Data Center Coalition board member. “By collaborating and sharing information with peers, it helps the entire sector move faster. It is our hope that through partnerships we can convince policy makers, stakeholders and supply chains of the HVO benefits and enlist their help in achieving the widespread production and distribution of the renewable fuel in markets that lack reliable, cost-effective and timely access today.”
“There is strong industry interest in transitioning from diesel as quickly as is practical. While there are no ‘silver bullet’ technological solutions available today to replace backup diesel generators at scale, data centers are actively seeking and evaluating alternatives that can provide environmental sustainability benefits and similar reliability, fuel availability, siting flexibility and workplace safety protections,” explained Josh Levi, president of the Data Center Coalition. “We are seeing widespread interest in leveraging hydrotreated vegetable oil as an alternative to conventional diesel. In fact, a recent member survey found that 92 percent of respondents are interested in piloting renewable diesel in the Northern Virginia market within the next one to two years. We’re pleased to see support for this sustainable fuel and will continue to work closely with member companies as we advocate to speed the viability and availability of alternative, reliable sources for backup energy.”
In addition to Vantage’s continued rollout of HVO, the company is also implementing generator run-time reduction measures to eliminate the creation of emissions from the start. By using an optimized staged implementation of testing and maintenance procedures, Vantage anticipates achieving a 25 to 75 percent reduction in fuel consumption and associated emissions. Vantage is also installing active emissions control systems known as Selective Catalytic Reductions (SCRs) on generators in select markets. SCRs reduce nitrogen oxide emitted from the company’s diesel generators by up to 90%. SCRs are already installed at many facilities across Vantage’s Warsaw, Berlin, Frankfurt and California campuses with additional installations planned for the future.
For more information about Vantage’s sustainability program and priorities, download the 2022 ESG report here.
About Vantage Data Centers
Vantage Data Centers powers, cools, protects and connects the technology of the world’s well-known hyperscalers, cloud providers and large enterprises. Developing and operating across five continents in North America, EMEA and Asia Pacific, Vantage has evolved data center design in innovative ways to deliver dramatic gains in reliability, efficiency and sustainability in flexible environments that can scale as quickly as the market demands.
For more information, visit http://www.vantage-dc.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230913529341/en/
Contact information
Press Contacts
Mark Freeman
Vantage Data Centers
mfreeman@vantage-dc.com
+1-202-680-4243
Robin Bectel
REQ for Vantage Data Centers
vdc@req.co
+1-202-936-6335
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
